Market Overview:
The global terlipressin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of liver diseases, rising geriatric population, and growing demand for terlipressin injections in hospitals and retail pharmacies. Based on type, the global terlipressin market can be segmented into 5ml vial injections and 10mL vial injections. The 5ml vial injection segment is expected to account for a larger share of the global market than the 10mL vial injection segment during the forecast period. This can be attributed to its lower price point as compared with 10mL vials and its higher demand in developing countries. Based on application, the global terlipressin market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment is expected to account for a larger share of the global market than other segments during the forecast period owing to rising demand for terlipressin injections in hospitals for treatment of various liver diseases such as cirrhosis and hepatitis C virus (HCV) infection.
Product Definition:
Terlipressin is a drug that is used to treat high blood pressure in the liver. It helps to decrease the amount of fluid that builds up in the abdomen and legs. Terlipressin may also be used for purposes not listed in this medication guide.
5ml vial Injections:
5ml vial Injections is a drug that is administered by subcutaneous injection. It contains the same amount of drug as in 50 ml vials, however it's volume is smaller due to its injectable form. This allows physicians to give higher doses of the medication and also reduces the possibility of side effects caused due to high concentration of drugs in larger volume.
10mL vial Injections:
Terlipressin is a peptide hormone, which is released by the body during sleep. It's primary function is to control the release of histamine from nerve cells in the brain. During sleep, there's a decrease in wakefulness and an increase in slow wave sleep (SWS). Slow wave sleep has been shown to be beneficial for healing wounds and reducing inflammation as well as pain perception.
Application Insights:
Based on the application, the global terlipressin market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment dominated the market in 2017 due to increasing prevalence of diabetes and rising demand for effective antidiabetic drugs. In addition, factors such as growing number of diabetic patients seeking treatment at hospitals along with an increase in healthcare awareness among individuals are expected to drive growth over the forecast period.
The online pharmacy sector is anticipated to witness significant growth during the forecast period owing to various benefits offered by them such as convenience and accessibility along with low cost compared to their offline counterparts. Furthermore, government initiatives aimed at promoting e-commerce businesses are further expected fuel industry expansion over next few years.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and distributors coupled with high healthcare expenditure, favorable reimbursement policies, and increasing patient awareness levels are some factors attributing to its largest share. In addition, the growing geriatric population is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising disposable income leading to an increase in demand for pharmaceutical products among patients as well as healthcare professionals. Moreover, improving economic conditions have led many people migrate from rural areas into urban cities where they can access better medical care at a lower cost; this trend is expected continue driving Terlipressin sales over the next eight years.
Growth Factors:
- Increasing incidence of liver cirrhosis: The major growth driver for the terlipressin market is the increasing incidence of liver cirrhosis. Terlipressin is used as a treatment for patients with ascites and hepatorenal syndrome. As the prevalence of these diseases increases, so will the demand for terlipressin.
- Growing awareness about terlipressin: There is growing awareness about the benefits of terlipressin among physicians and patients alike. This is likely to lead to an increase in demand for this drug in the coming years.
- Availability of generic versions: The availability of generic versions of terlipressin has made it more affordable and accessible to a larger population base worldwide. This is likely to boost demand for this drug in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Terlipressin Market Research Report
By Type
5ml vial Injections, 10mL vial Injections
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
EVER Pharma, Hybio Pharmaceutical, Sun Pharmaceutical Industries Ltd., Shanghai Soho-Yiming Pharmaceuticals, Xi 'an langene biological technology, SGPharma, Maya Biotech, Hangzhou Huadi Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Terlipressin Market Report Segments:
The global Terlipressin market is segmented on the basis of:
Types
5ml vial Injections, 10mL vial Injections
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EVER Pharma
- Hybio Pharmaceutical
- Sun Pharmaceutical Industries Ltd.
- Shanghai Soho-Yiming Pharmaceuticals
- Xi 'an langene biological technology
- SGPharma
- Maya Biotech
- Hangzhou Huadi Group
Highlights of The Terlipressin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5ml vial Injections
- 10mL vial Injections
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Terlipressin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Terlipressin is a hormone that is used to treat depression and anxiety. It works by increasing the amount of serotonin in the brain.
Some of the key players operating in the terlipressin market are EVER Pharma, Hybio Pharmaceutical, Sun Pharmaceutical Industries Ltd., Shanghai Soho-Yiming Pharmaceuticals, Xi 'an langene biological technology, SGPharma, Maya Biotech, Hangzhou Huadi Group.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Terlipressin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Terlipressin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Terlipressin Market - Supply Chain
4.5. Global Terlipressin Market Forecast
4.5.1. Terlipressin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Terlipressin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Terlipressin Market Absolute $ Opportunity
5. Global Terlipressin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Terlipressin Market Size and Volume Forecast by Type
5.3.1. 5ml vial Injections
5.3.2. 10mL vial Injections
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Terlipressin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Terlipressin Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Terlipressin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Terlipressin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Terlipressin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Terlipressin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Terlipressin Demand Share Forecast, 2019-2026
9. North America Terlipressin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Terlipressin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Terlipressin Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Terlipressin Market Size and Volume Forecast by Type
9.7.1. 5ml vial Injections
9.7.2. 10mL vial Injections
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Terlipressin Demand Share Forecast, 2019-2026
10. Latin America Terlipressin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Terlipressin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Terlipressin Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Terlipressin Market Size and Volume Forecast by Type
10.7.1. 5ml vial Injections
10.7.2. 10mL vial Injections
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Terlipressin Demand Share Forecast, 2019-2026
11. Europe Terlipressin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Terlipressin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Terlipressin Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Terlipressin Market Size and Volume Forecast by Type
11.7.1. 5ml vial Injections
11.7.2. 10mL vial Injections
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country 11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Terlipressin Demand Share, 2019-2026
12. Asia Pacific Terlipressin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Terlipressin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Terlipressin Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Terlipressin Market Size and Volume Forecast by Type
12.7.1. 5ml vial Injections
12.7.2. 10mL vial Injections
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Terlipressin Demand Share, 2019-2026
13. Middle East & Africa Terlipressin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Terlipressin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Terlipressin Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Terlipressin Market Size and Volume Forecast by Type
13.7.1. 5ml vial Injections
13.7.2. 10mL vial Injections
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Terlipressin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Terlipressin Market: Market Share Analysis
14.2. Terlipressin Distributors and Customers
14.3. Terlipressin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. EVER Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hybio Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sun Pharmaceutical Industries Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shanghai Soho-Yiming Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Xi 'an langene biological technology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. SGPharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Maya Biotech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hangzhou Huadi Group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
